The synthesis of 1,3-Difluoro-2-methyl-4-phenylbenzene from a      one-pot reaction of Difluorocarbene and 1-Phenyl-2-methylcyclobutene by Menger, Ruth Felicitas
James Madison University
JMU Scholarly Commons








Follow this and additional works at: https://commons.lib.jmu.edu/honors201019
Part of the Medicinal-Pharmaceutical Chemistry Commons, Organic Chemicals Commons, and
the Organic Chemistry Commons
This Thesis is brought to you for free and open access by the Honors College at JMU Scholarly Commons. It has been accepted for inclusion in Senior
Honors Projects, 2010-current by an authorized administrator of JMU Scholarly Commons. For more information, please contact
dc_admin@jmu.edu.
Recommended Citation
Menger, Ruth Felicitas, "The synthesis of 1,3-Difluoro-2-methyl-4-phenylbenzene from a one-pot reaction of Difluorocarbene and
1-Phenyl-2-methylcyclobutene" (2016). Senior Honors Projects, 2010-current. 232.
https://commons.lib.jmu.edu/honors201019/232
The Synthesis of 1,3-Difluoro-2-methyl-4-phenylbenzene from a      
one-pot Reaction of Difluorocarbene and 1-Phenyl-2-methylcyclobutene 
_______________________ 
 
An Honors Program Project Presented to 
 
the Faculty of the Undergraduate 
 
College of Science and Mathematics 
 










Accepted by the faculty of the Department of Chemistry and Biochemistry, James Madison University, in partial 





       
Project Advisor:  Scott Lewis, Ph.D. 
Associate Professor, Chemistry 
 
 
       
Reader:  Kevin Caran, Ph.D. 
Associate Professor, Chemistry 
 
 
       
Reader:  Donna Amenta, Ph.D. 
Professor, Chemistry 
 
HONORS PROGRAM APPROVAL: 
 
 
       
Bradley R. Newcomer, Ph.D., 




This work is accepted for presentation, in part or in full, at Spring Symposium on April 14, 2015 . 
 
2 
Table of Contents 
List of Figures                                3 
Acknowledgements                             4 
Abstract                               5 
Chapter 1: Introduction                              6 
Chapter 2: Mechanistic and Synthetic Explanation                       14 
Chapter 3: Results and Discussion                        18 
Chapter 4: Experimental                         22 
References                            24 



















List of Figures 
1. Examples of fluoroaromatic compounds with pharmaceutical applications            7 
2. Blocking of unproductive metabolic pathways by fluorination of an inhibitor of 
cholesterol absorption                   8 
3. Structure of mefloquine, used to treat malaria               9 
4. Examples of fluorinated fungicides               10 
5. Examples of fluorinated insecticides               10 
6. Balz-Schiemann fluorination of aryl diazonium tetrafluoroborates           11 
7. Electrophilic aromatic substitution               12 
8. Fluorine direct electrophilic aromatic substitution             12 
9. Examples of industrially useful compounds with 1,3-difluorobenzene moieties         12 
10. Reaction of Seyferth’s reagent and 1,2-diphenylcyclobutene to make  
1,3-difluoro-2,4-diphenylbenzene               14 
11. Formation of difluorocarbene from Seyferth’s reagent            14 
12. Proposed cationic mechanism of the addition of 1 mol difluorocarbene to disubstituted 
cyclobutene                  15 
13. Addition of the second mole of difluorocarbene             15 
14. Possible isomers formed from the reaction of difluorocarbene with  
1-phenyl-2-methylcyclobutene               16 
15. Resonance structure differences between fully and cross conjugated systems         17 
16. Overall reaction scheme                18 
17. Magnified view of aromatic region of 1H NMR of  




 Without the help of many people, this project would never have been a success. I would 
first like to thank the collective faculty of the Department of Chemistry and Biochemistry at 
James Madison University for the preparation they have provided in all aspects of chemistry. 
Without their teaching, I never would have become interested in research and delving further 
into solving the mysteries of organic chemistry. To my readers, Drs. Donna Amenta and Kevin 
Caran, thank you for providing the expertise in organic chemistry to fill in the blanks and make 
my writing comprehensive. Drs. Jun Yin and Daniel Ralston, you were invaluable in assisting 
with the use and interpretation of the NMR and GC-MS, respectively. My biggest thanks goes to 
my advisor, Dr. Scott Lewis. Your organic chemistry class is the one class that inspired me to 
pursue a career in chemistry. I am incredibly thankful for your continued support and guidance 
over the past three years. I can only dream of being a professor and advisor as inspirational as 
you have been. And finally, I cannot thank my parents enough for instilling in me a curiosity and 
drive that ultimately led to the desire to take on this project. Your support and encouragement 














Previous studies show that 1,2-disubstituted cyclobutenes can be used in reaction with 
difluorocarbene to produce 1,3-difluorobenzenes. A pathway to the synthesis of these types of 
compounds is of interest due to their presence in fluoroquinolone antibacterials, resins, and 
insecticides. The synthesis is unique because the fluorine atoms from the difluorocarbene are not 
adjacent to each other when the ring expands to a benzene ring. This study focuses on the 
reaction of difluorocarbene with 1-phenyl-2-methylcyclobutene, which was synthesized in one-




















One of the most unique elements that has yet to be fully explored is fluorine.  Since first 
being successfully isolated by Ferdinand Frederic Henri Moissan in 1886, it has been used in a 
variety of industries, from medicine and health, to agriculture and synthetic polymers.
1
 With an 
electronegativity value of 4.0, the highest of all the elements, fluorine has the capability of 
reacting with almost any element.  Despite its high reactivity, it can still form some of the most 
stable and inert substances, such as Teflon.  Some common applications include fluoride in 




Elemental fluorine is extremely toxic and corrosive. When in contact with organic 
compounds, it will spontaneously combust or explode. Its unique smell, similar to a mixture of 
chlorine and ozone, is detectable by smell even at 10 ppm. Elemental fluorine is so unusual, it 
can even react with noble gases like krypton and xenon. Its homolytic dissolution into radicals 
makes it dangerous for living organisms but also contributes to its reactivity, causing high redox 
potentials. Due to its high electronegativity, smallest ion size (ion radius 133 pm) and being the 
least polarizable monatomic anion, it can stabilize other elements in their highest and otherwise 
inaccessible oxidation states. The compatible size also make it an excellent match for the 
corresponding 2s or 2p orbitals of carbon, producing a highly polar bond with a dipole moment 
of around 1.4 D. The strength of this bond (think Teflon) and the electrostatic interactions that 
result from the polarity lend themselves to be very useful in a variety of industries.
3
   
Interestingly, fluorine has been found to have an increasingly larger effect on the 
pharmaceutical industry over the past few decades. Despite its reactivity, the chemical and 
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physical properties of fluorine have been utilized to increase the efficacy of a number of drugs to 
treat all kinds of diseases (Figure 1).
4
 In general, pharmaceuticals depend on a specific 
interaction with a target structure in an organism. The strength of this interaction can be 
determined by the structure of the drug which then affects its function. Fluorine has become an 
obvious choice to replace a hydrogen atom. Both atoms are similar in size so the replacement 
will not significantly change the size or geometry of the molecule due to steric hinderance. 
However, because fluorine is so electronegative, it can greatly affect the functionality of a part of 
the molecule and change its interactions with other molecules.
3
 It changes the electron 




The replacement of hydrogen with fluorine also increases the lipophilicity of the 
molecule, which affects resorption. This helps the drugs get to their target organ more quickly. 
Figure 1. Examples of fluorine-containing pharmaceuticals: non-steroidal anti-inflammatory drugs (Roflumilast, 
Celebrex), modulators of cholesterol metabolism (Cerivastatin, Ezetimibe), anti-depressants (Fluoxetine), 





Additionally, drugs that target the central nervous system need a specific lipophilicity to cross 
the blood-brain barrier so the degree of fluorination can be used to manipulate this property. The 
electronegativity of fluorine substituents on aromatic rings renders the other aromatic hydrogen 
atoms more acidic, contributing to their potential as hydrogen bond donors.
3
  
The replacement of hydrogen with fluorine can also prevent excessively rapid 
degradation of the drug. Metabolic pathways that usually depend on the functionality of 
hydrogen will be rendered useless with a fluorine in that position instead. The select placement 
of a fluorine atom can prevent the premature degradation of the drug, leaving the intended 
reaction sites open for the biological activation of the prodrug.
3
 For example, Figure 2 shows the 
Figure 2. Blocking of unproductive metabolic pathways by fluorination as a design tool for an orally active 
inhibitor of cholesterol absorption. The result of this rational approach (SCH 58235) is 50 times more active than 





changes made in an orally active inhibitor of cholesterol absorption to prevent oxidation and 
increase efficacy. Without fluorine atoms on the left and right phenyl groups, one phenyl group 
is oxidated while the methoxy substituent becomes demethylated under normal biological 
conditions. The addition of fluorine atoms prevents this “non-productive” metabolism and helps 
activate the metabolism that is needed for the activation of the drug. It was found that this change 
increased activity by 50 times compared to the starting compound.
6
  
The presence of fluorine on aromatic rings (and thus the synthesis of aryl fluorides) is of 
particular interest. In fact, more than 20% of pharmaceuticals currently contain fluorinated 
aromatic substructures.
3
 These are mostly fluoroquinolones, which are a group of antibacterial 
drugs that are necessary to combat infections that have arisen due to the growing resistance to the 
traditional antibacterials like penicillins, cephalosporins, and tetracyclines. Norfloxacin was one 
of the first to be introduced in 1980. Since then, many more fluorine-containing antibacterials 
have been designed and produced. They have been found to treat a multitude of diseases, 
including lower respiratory, urinary tract, and prostate infections. The only current treatment for 









The agricultural industry has even more applications of fluorinated aromatic substances, 
making up more than 50% of newly introduced compounds. Although it can be more expensive 
Figure 3. Structure of mefloquine, used to treat malaria.  
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to make these compounds, the increased effectiveness greatly outweighs the cost. This reduces 
the amount of chemicals that need to be put into the environment, making it safer overall. 
Fluorine is found in herbicides, insecticides, and pesticides. Fungicides in particular have been 
synthesized with fluorine attached to a benzene moiety integrated into the molecule (Figure 4). 
They act as sterol biosynthesis inhibitors by blocking a crucial demethylation step in ergosterol  
biosynthesis. Insecticides like benzoylureas function by inhibiting chitin biosynthesis (Figure 5).
5
 
Figure 4. Examples of fluorinated fungicides that function as sterol biosynthesis inhibitors.
 5
 






The use of fluoroaromatics in these various industries presents the need for an effective 
and selective synthetic method. Fluorobenzenes have proven to be especially difficult to 
synthesize.   Previous pathways of achieving this aromatic C-F bond resulted from the reaction 
of aromatic C-H bonds with F2; however, this reaction often produces large amounts of explosive 
waste.
3
 Another synthetic route is the Balz-Schiemann reaction, which is still the primary 
method of fluorinating benzene rings. This multi-step process involves the diazotization of an 
aromatic amine in the presence of tetrafluoroboric acid (Figure 6). However, this reaction also 
produces a large amount of waste, which is something to avoid, especially in a large-scale 
manufacturing industry. It has been a long-standing goal to make the production of 








The synthesis of fluorobenzene leads one to attempt to synthesize difluorobenzenes. This 
problem proves to be even more difficult due to the extreme electronegativity of the fluorine 
atoms and its directing influence during a typical electrophilic aromatic substitution reactions. 
During an EAS reaction, an electrophile interacts with the π system of the electron-rich benzene. 
A carbocation intermediate is created but is stabilized by resonance and then an aromatic proton 
is lost to restore the aromatic six-membered ring (Figure 7). Fluorine has the ability to donate 
electrons to participate in resonance, stabilizing the ring, but also directing the next atom to 
attach to the ortho or para position, to yield 1,2- or 1,4-difluorobenzene (Figure 8). In addition, 





once on the ring, fluorine deactivates the ring by inductively withdrawing electron density away 
from the ring, making it difficult to add any additional substituents. For fluorine (and the other 
halogens) the inductive withdrawal is great than the resonance donation, leading to a net 
deactivation towards electrophilic aromatic substitution.   
This leaves a large gap in the literature for methods to achieve a 1,3 orientation on a 
benzene ring. This moiety is present in compounds like Hexaflumuron, Ci-934, and Diflunisal. 
Hexaflumuron is sold as a commercially useful termite poison
8
 while compound CI-934 is a 
potent antibacterial agent against Gram-positive isolates
9
 and Diflunisal is a steroidal anti-
inflammatory drug. Used to treat arthritis pain, its mechanism of action involves preventing 




















Figure 8. Fluorine directed electrophilic aromatic substitution of a second substituent to the ortho position.  
Electrophilic aromatic substitution. Addition to the para position would yield similar resonance structures. 
Figure 7. Electrophilic aromatic substitution. 
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This leads to the purpose of this project – to improve the methodology of synthesizing 
1,3-difluorobenzenes but not by the reaction of elemental fluorine to an already intact benzene 
ring. We propose the reaction of substituted cyclobutenes with difluorocarbene to achieve a 
difluorobenzene with the fluorine atoms meta to each other.  In addition to adding to the 
literature by discovering more about the mechanism of this reaction, the resulting compounds 























Mechanistic and Synthetic Explanation 
In 1994, Lewis and Borden presented the use of difluorocarbene to synthesize a 
difluorobenzene via a cyclobutene intermediate. This ring expansion was achieved by the 
addition of Seyferth’s reagent (phenyl(trifluoromethyl)mercury(II)) to 1,2-diphenylcyclobutene 
(Figure 10). Later it was shown the synthesis could be successful using various substituted 
cyclobutenes.
11
 The use of a non-benzene precursor for the synthesis of fluorobenzenes 
eliminates the production of large amounts of explosive waste that comes from the                 
Balz-Schiemann reaction. Hopefully the ability to produce compounds with a larger variety of 




Difluorocarbene is very reactive and has a short half-life on its own, justifying the use of 
Seyferth’s reagent, Ph-Hg-CF3. The precursor undergoes an SN2 style reaction in the presence of 
NaI, replacing the trifluoromethyl group with iodine. The leaving group, 
-
CF3, is unstable and 
spontaneously separates into a fluoride ion and difluorocarbene (Figure 11). The difluorocarbene 
is now free to attack the cyclobutene.  
 
 
Figure 10. Reaction of Seyferth’s reagent and 1,2,-diphenylcyclobutene to make 1,3-difluoro-2,4-diphenylbenzene. 
Figure 11. Formation of difluorocarbene from Seyferth’s reagent. 
I
NaI




This reaction is believed to follow a cationic mechanism (Figure 12). When the 
difluorocarbene is added to the cyclobutene, it forms a strained housane intermediate. One 
fluoride ion leaves, allowing the ring to expand and relieving the strain. The allylic ion expands 
into a five-membered ring. A proton is immediately expelled, forming a double bond and leaving 
behind an even more stable, neutral fluorocyclopentadiene structure. A second equivalent of 
difluorocarbene is then added and reacts with the non-fluorinated double bond of the 
cyclobutadiene (Figure 13). It is thought that the non-fluorinated double bond is attacked in the 
second step because it is more electron rich than the other double bond, which is under the 
electron withdrawing effect of the fluorine substituent.
11
 The 1,3-difluorobenzene is complete 







Figure 12. Proposed cationic mechanism of the addition of 1 mol difluorocarbene to disubstituted cyclobutene. 
Figure 13. Addition of the second mole of difluorocarbene. 
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This cationic mechanism is consistent with the results of reactions using symmetrically 
substituted cyclobutenes as precursors. This study investigates an asymmetric cyclobutene which 
will result in the possible formation of various isomers (Figure 14). By determining which 
isomer is the major one, the validity of the cationic mechanism can be determined. Using a 
cation-stabilizing substituent like benzene should allow for the control of the preferred location 




Investigation of the potential cyclopentadiene intermediates shows differences in stability 
based on the orientation of the π system. The presence of a phenyl group on the cyclopentadiene 
provides the possibility for conjugation or cross-conjugation. This is related to a conjugated π 
system, where an alternating pattern of single and double bonds allows the general delocalization 
of electrons. The flow of electrons through the system stabilizes the molecule, which is present 
in benzene for example. Cross conjugation occurs when only a limited number of a set of π 
bonds interact with each other. While these molecules may look like normally conjugated 













































molecules, inspection of their resonance structures shows that not all the π bonds participate in 
resonance (Figure 15). The cross-conjugated molecules are higher in energy because of reduced 
intramolecular electron delocalization and resonance capability than are their fully conjugated 
systems relatives.
12
 Of the two potential intermediates that would be formed by the cationic 
mechanism, one is cross-conjugated and one is fully conjugated, leading to the formation of 
compounds 1 and 3 respectively (Figure 14). The identification of the major isomer formed will 
provide more evidence toward the validity of this cationic mechanism and the ability to use this 

















Figure 15. Resonance structure differences between fully conjugated (top) and cross conjugated (bottom) 
systems.  
This double bond is not 




Results and Discussion 
The synthesis of 1,3-difluoro-2-methyl-4-phenylbenzene was achieved by the addition of 
Seyferth’s reagent (Ph-Hg-CF3) to 1-phenyl-2-methylcyclobutene (Figure 16). A solution of      
1-phenyl-2-methylcyclobutene (5) was added to dried NaI and Seyferth’s reagent. After heating 
to reflux for 24 hours, the reaction was filtered and concentrated.  
Previous attempts have shown this reaction with Seyferth’s reagent to be very 
temperamental. The reagent itself is not reliable to work on a consistent basis. The reaction will 
also only work if the starting cyclobutene is extremely pure. The purification of this molecule 
was found to be difficult, especially the separation from its starting material,            
Z-1,4-diiodo-4-phenyl-3-methyl-3-butene (4). Extreme care was taken to combine only the 
fractions of the column that had completely separated products. All reagents used in the ring 
expansion reaction were dried under vacuum to ensure the absence of water. Despite these 
efforts, trace contaminants could still prevent the production of the 1,3-difluorobenzene product.  
Figure 16. Overall reaction scheme. 


















 The product 3 was characterized using GC/MS, which showed the major peak at 6.5 
minutes with a parent ion peak having a 204 mass to charge ratio. This matches the expected 
value for either isomer of the difluorobenzene that was expected from this reaction. A 
19
F NMR 
confirmed the addition of two fluorine atoms and therefore the structure of 3 (Figure 16). 
Aromatic fluorine atoms have a chemical shift in the -100 to -150 ppm region. Two signals were 
found at around -120 ppm which are consistent with expected peaks for the placement of the 
fluorine atoms on the benzene ring. With the purification of the product, exact peaks could be 
assigned but due to impurities, just the existence of signals in the aromatic region confirms the 
addition of two fluorine atoms to the benzene ring. The exact structure was confirmed by the 
cleaner 
1
H NMR.  
The 
1
H NMR showed interesting coupling due to the fluorine atoms and confirmed that 
isomer 3 was formed, with the methyl group situated between the two fluorine atoms on the 
benzene ring. Since fluorine is similar to hydrogen in size, there is very strong coupling between 
Figure 17. Magnified view of aromatic region of 
1
H NMR of 1,3-difluoro-2-methyl-4-phenylbenzene 3. 
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protons and fluorine atoms. Fluorine can couple up to seven bonds away due to electron pairs, 
causing extra splitting in the 
1
H spectrum. The peak assigned to the protons on the methyl 
substituent at 2.09 ppm (J = 5.16 Hz) appeared to be a triplet because of coupling from fluorine 
atoms on either side of it. The presence of a doublet in this peak would suggest only one fluorine 
neighbor and the formation of isomer 1, with the phenyl group in between the two fluorine atoms 
instead of the methyl group. 
A magnified view of the aromatic region of the 
1
H NMR of 3 showed two smaller peaks 
on either side of the multiplet assigned to the phenyl substituent group at 7.39 ppm (Figure 17). 
An apparent triplet was found at 7.14 ppm (J = 7.65 Hz) and a doublet of doublets was found at 
7.72 ppm (J = 8.34 Hz, J = 1.17 Hz). These were assigned to Hb, next to Fb, and Ha, next to the 
phenyl substituent, respectively. These splitting patterns are expected with the structure of this 
isomer. The atom Fb and Ha split Hb at 7.14 ppm into an apparent triplet while Fa and Hb split Ha 
at 7.72 ppm into a doublet of doublets. This splitting pattern combined with the splitting of the 
methyl substituent protons supports the formation of isomer 3 over isomer 1 and provides further 
evidence for the validity of a cationic mechanism with a fully conjugated fluorocyclopentadiene 
intermediate for the addition of difluorocarbene to an asymmetric disubstituted cyclobutene.   
It has not yet been confirmed whether Seyferth’s reagent can be recommended without a 
doubt for the use of this ring expansion reaction to make 1,3-difluorobenzenes. The lack of 
consistent success of the reaction invites further studies to improve the reaction. Other 
investigations are being done using differently substituted alkenes to make various cyclobutenes. 
This will demonstrate the regioselectivity of the reaction and how substituents with different 
sizes and properties affect the reaction. It is still a desire to declare with more certainty the 
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All reagents were used as received from the manufacturer. All solutions were prepared in 
dry solvents from the solvent purification system separately right before use and cannula 
transferred to the reaction flask. All reactions were performed under inert gas conditions. Product 
concentration was accomplished using a Buchi Rotavapor R-114. An Agilent 6890N gas 
chromatograph with an HP-5MS 0.25mm x 30m x 0.25 um column coupled to an Agilent 6460 
triple quadrupole (QqQ) mass spectrometer was used to confirm products. A Bruker 400 MHz 
NMR was used to characterize all products. CDCl3 was used as the solvent, and chemical shifts 
are reported in ppm downfield from tetramethylsilane (δ scale). Procedures were modified from 




Preparation of Z-1,4-diiodo-4-phenyl-3-methyl-3-butene (4) 
Compound 1 was prepared by dissolving 1.26 g ZrCp2Cl2 (4.3 mmol) in dry THF in a 
250 mL round bottomed flask. To this, 4.5 mL EtMgBr (8.6 mmol) in ether was added dropwise 
to the flask and reaction allowed to stir at -78°C for one hour. Phenylpropyne (0.5 g, 4.3 mmol) 
in dry THF was added and stirred at 0°C for 6 hours and at room temperature overnight. The 
reaction was brought back to 0°C before adding 3.28 g I2 (12.9  mmol) in dry THF and stirred at 
room temperature overnight. Work-up involved removal of THF under reduced pressure 
followed by the addition of ether. The ether solution was treated with 3M HCl and allowed to stir 
for 10 minutes. The organic layer was separated and sequentially washed with 10% NaHCO3 and 
10% Na2SO3. The organic layer was retained, dried over Na2SO4, gravity filtered, and 
concentrated. The crude product was purified on a silica gel column eluted with cyclohexanes to 
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give a yield of 64%. The structure of the product was confirmed by GC-MS and NMR analyses. 
1
H NMR (CDCl3) δ: 1.78 (s, 3H), 3.04 (t, 2H, J = 7.52), 3.35 (t, 2H, J = 6.96), 7.28 (m, 5H); 
GC/MS (EI) m/z = 272, r.t. = 18 min.  
 
Preparation of 1-phenyl-2-methylcyclobutene (5) 
Pure products of 1 were combined and solvent was removed in vacuo. Dry ether was 
added to 500 mg of product (1.837 mmol), followed by the syringe addition of 0.346 mL           
n-butyllithium (3.675 mmol, 2.5 M in hexanes). The reaction was stirred for 1 hour at -78°C, 
after which 1 mL H2O was added to quench the reaction. The reaction was allowed to stir until 
coming to room temperature. Crude product was purified on a silica gel column eluted with 
pentanes to give a yield of 17%. The structure of the product was confirmed by GC-MS and 
NMR analyses. 
1
H NMR (CDCl3) δ: 1.28 (m, 4H), 1.56 (s, 3H), 7.29 (m, 5H); GC/MS (EI)     
m/z = 115, r.t. = 7 min.  
 
Preparation of 1,3-difluoro-2-methyl-4-phenylbenzene (3) 
A large excess of NaI was ground into a powder in a mortar and pestle and then added to 
a    25-mL 3-necked round bottom flask with a stir bar. It was dried under vacuum at 150°C for 
24 hours. Phenyl(trifluoromethyl)mercury(II) (Seyferth’s reagent) (264 mg, 0.763 mmol) was 
added to the flask and dried under vacuum at room temperature for 24 hours. A solution of       
10 mL dry benzene (Na/benzophenone) added to 50 mg of 2 (0.347 mmol) was added to the 
reaction flask. The flask was heated to reflux for 24 hours. The structure of the product solution 
was gravity filtered. The product was confirmed by GC-MS and NMR analyses. 
1
H NMR 
(CDCl3) δ: 2.09 (apparent t, 3H, J = 5.16), 7.13 (t, 1H, J = 7.65), 7.39 (m, 5H), 7.72 (d, 1H,        
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